Summit Therapeutics
SMMT
#1915
Rank
โ‚ฌ9.09 B
Marketcap
12,22ย โ‚ฌ
Share price
-1.17%
Change (1 day)
-36.84%
Change (1 year)

Market capitalization of Summit Therapeutics (SMMT)

Market cap: โ‚ฌ9.09 Billion

As of February 2026 Summit Therapeutics has a market cap of โ‚ฌ9.09 Billion. This makes Summit Therapeutics the world's 1915th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Summit Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ9.09 B-20.87%
2025โ‚ฌ11.49 B-10.92%
2024โ‚ฌ12.90 B679.89%
2023โ‚ฌ1.65 B107.45%
2022โ‚ฌ0.79 B243.67%
2021โ‚ฌ0.23 B-26.16%
2020โ‚ฌ0.31 B227.6%
2019โ‚ฌ95.94 M480.13%
2018โ‚ฌ16.53 M-88%
2017โ‚ฌ0.13 B37.73%
2016โ‚ฌ0.10 B-22.38%
2015โ‚ฌ0.12 B

End of Day market cap according to different sources

On Feb 3rd, 2026 the market cap of Summit Therapeutics was reported to be:

โ‚ฌ9.20 Billion
by Nasdaq info icon info icon
โ‚ฌ9.20 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
โ‚ฌ1.75 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
โ‚ฌ0.18 B-97.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
โ‚ฌ0.22 B-97.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
โ‚ฌ5.22 B-42.57%๐Ÿ‡บ๐Ÿ‡ธ USA